# Role of Rapid On-site Evaluation for Mutational Analysis of EBUS-TBNA Specimens

> **NCT01799382** · NA · COMPLETED · sponsor: **Maggiore Bellaria Hospital, Bologna** · enrollment: 126 (actual)

## Conditions studied

- Non-small Cell Lung Cancer

## Interventions

- **OTHER:** Rapid on-site evaluation
- **DEVICE:** EBUS-TBNA

## Key facts

- **NCT ID:** NCT01799382
- **Lead sponsor:** Maggiore Bellaria Hospital, Bologna
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-02
- **Primary completion:** 2014-10
- **Final completion:** 2014-10
- **Target enrollment:** 126 (ACTUAL)
- **Last updated:** 2014-10-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01799382

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01799382, "Role of Rapid On-site Evaluation for Mutational Analysis of EBUS-TBNA Specimens". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01799382. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*